The abstract is read at the publisher; the summary is JClub's.
In two type 2 diabetes mouse models, inulin-fermented butyrate prevents ferroptosis-driven diabetic cardiomyopathy by restoring cardiac iron homeostasis and suppressing ferroptosis.
- Why it matters: Dysregulated iron metabolism and ferroptosis contribute to diabetic cardiomyopathy, but the regulatory pathway and an effective therapeutic strategy were unclear.
- What they did: The study used high-fat diet plus streptozotocin and db/db mice, plus an iron chelator, and tested inulin with an SCFA inhibitor; it also used HIF-1α interference in vivo and in vitro.
- The result: Butyrate most strongly inhibited ferroptosis, and its effect depended on HIF-1α: butyrate reduced HIF-1α ubiquitination by inducing HIF-1α butyrylation at lysine 190, increasing FTH and FTMT to store unstable iron.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.